| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 02/17/1999 | EP0897008A2 His5 |
| 02/17/1999 | EP0897004A2 Histidyl tRNA synthetase from Streptococcus pneumoniae (hisS) |
| 02/17/1999 | EP0896820A1 Ophthalmic composition comprising naloxone and at least one polyhydric alcohol |
| 02/17/1999 | CN1208035A Dithiolan derivatives, their preparation and their therapeutic effect |
| 02/17/1999 | CN1208034A Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 02/16/1999 | US5872226 Fibroblast growth factor homologous factor-1 (FHF-1) |
| 02/16/1999 | US5872146 Metalloproteinases involved in connective tissue breakdown, such as collagenase, stromelysin and gelatinase and tumor necrosis factor |
| 02/16/1999 | CA2021576C Agent for preventing and treating opacity of lens |
| 02/13/1999 | CA2240627A1 Novel ratc |
| 02/13/1999 | CA2240623A1 Novel rata |
| 02/12/1999 | CA2239837A1 Novel murd |
| 02/12/1999 | CA2239819A1 Ftsz |
| 02/11/1999 | WO1999006433A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006404A1 1,2,4-triazolo[4,3-b]pyrido[3,2-d]pyridazine derivatives and pharmaceutical compositions containing them |
| 02/11/1999 | WO1999006391A1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof |
| 02/11/1999 | WO1999006390A1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006340A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 02/11/1999 | WO1999006070A1 Switchable viscoelastic systems containing galactomannan polymers and borate |
| 02/11/1999 | WO1999006065A1 Aqueous preparation of lactoferrin having improved stability |
| 02/11/1999 | WO1999006064A1 Method for preventing and treating hearing loss using a neurturin protein product |
| 02/11/1999 | WO1999006060A1 Methods for treating neurological deficits |
| 02/11/1999 | WO1999006053A1 N6-substituted-adenosine-5'-uronamides as adenosine receptor modulators |
| 02/11/1999 | WO1999006041A1 SUBSTITUTED ALKANOHYDROXAMIC ACIDS AND METHOD OF REDUCING TNFα LEVELS |
| 02/11/1999 | WO1999006025A1 Method and compositions for treating late phase allergic reactions and inflammatory diseases |
| 02/11/1999 | WO1999006023A1 Ophthalmic compositions containing galactomannan polymers and borate |
| 02/11/1999 | CA2298935A1 1,2,4-triazolo[4,3-b]pyrido[3,2-d]pyridazine derivatives and pharmaceutical compositions containing them |
| 02/11/1999 | CA2298617A1 Acyclic metalloprotease inhibitors |
| 02/11/1999 | CA2298506A1 Methods for treating neurological deficits |
| 02/11/1999 | CA2296485A1 N6-substituted-adenosine-5'-uronamides as adenosine receptor modulators |
| 02/11/1999 | CA2295295A1 Substituted alkanohydroxamic acids and method of reducing tnf.alpha. levels |
| 02/11/1999 | CA2290746A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2239836A1 Novel arginine deiminase |
| 02/11/1999 | CA2239813A1 Novel nrdd |
| 02/11/1999 | CA2239221A1 Novel his5 |
| 02/10/1999 | EP0895474A1 Liquid eye drop composition |
| 02/10/1999 | CN1207684A Enzymatic method and compositions for treating intravitreal hemorrhagic blood |
| 02/10/1999 | CN1207680A Use of certain isoquinolinesulfonyl compounds for treatment of glaucoma and ocular ischemia |
| 02/10/1999 | CN1207675A Sublingual and buccal administration of selegiline |
| 02/10/1999 | CN1207322A Eye drops for treating conjunctivitis and preparing process thereof |
| 02/09/1999 | US5869663 Intermediates for neurokinin receptor antagonists |
| 02/09/1999 | US5869511 Isoxazoline compounds as inhibitors of TNF release |
| 02/09/1999 | US5869468 Treating glaucoma |
| 02/09/1999 | US5869086 Systems for the controlled release of pilocarpine |
| 02/09/1999 | US5869037 Adenoviral-mediated gene transfer to adipocytes |
| 02/09/1999 | CA2151385C Ophthalmic compositions comprising emedastine and their use for treating allergic conjunctivitis |
| 02/06/1999 | CA2239256A1 Novel lgt |
| 02/05/1999 | CA2239817A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 02/05/1999 | CA2239270A1 Novel phosphoribosyl transferase |
| 02/05/1999 | CA2238673A1 Novel aminopeptidase |
| 02/04/1999 | WO1999005155A2 Salts of di(uridine 5'-tetraphosphate), method for preparation and uses thereof |
| 02/04/1999 | WO1999005096A2 Urokinase inhibitors |
| 02/04/1999 | WO1999004782A1 Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides |
| 02/04/1999 | CA2294300A1 Urokinase inhibitors |
| 02/03/1999 | EP0894862A2 Novel CysS |
| 02/03/1999 | EP0894861A2 Glycogen phosphorylase from Streptococcus pneumoniae |
| 02/03/1999 | EP0894806A1 Novel pheS |
| 02/03/1999 | EP0894789A1 Substituted indole-2-carboxylic acids as glucosyl transferase inhibitors |
| 02/03/1999 | EP0894144A2 Diagnosing trinucleotide repeat diseases and genes involved therein |
| 02/03/1999 | EP0894009A1 Improved vision through photodynamic therapy of the eye |
| 02/03/1999 | EP0510186B1 Therapeutic uses of melanin |
| 02/03/1999 | CN1041923C Piperzine derivatives and preparation process and usage thereof |
| 02/02/1999 | US5866717 Metalloproteinase inhibitors |
| 02/02/1999 | US5866693 Detecting mutations in the polynucleotides encoding the madr3 or madr4 and for detecting altered levels of the polypeptide in a host. |
| 02/02/1999 | US5866605 Method for providing a neuroprotective effect to the mammalian eye by administration of chloride channel blockers |
| 02/02/1999 | US5866588 Dual histamine (h1) and platelet activating factor (paf) receptor antagonists. |
| 02/02/1999 | US5866578 Substituted pyrimidines for control of diabetic complications |
| 02/02/1999 | US5866370 Polynucleotides and polypeptides of the m29 aminopeptidase family, hereinafter referred to as ?aminopeptidase.? |
| 02/02/1999 | US5866366 gidB |
| 02/02/1999 | US5866157 Matrix patch formulation |
| 02/02/1999 | US5866120 Therapy for vision defects |
| 02/02/1999 | CA2053275C Fibroblast growth factor conjugates |
| 01/29/1999 | CA2243882A1 Substituted indole-2-carboxylic acids as glucosyl transferase inhibitors |
| 01/29/1999 | CA2239266A1 Novel histidine kinase |
| 01/28/1999 | WO1999003817A2 Aliphatic propargylamines as cellular rescue agents |
| 01/28/1999 | WO1999003503A1 The use of angiostatic steroids in photodynamic therapy |
| 01/28/1999 | CA2296558A1 The use of angiostatic steroids in photodynamic therapy of ocular neovascularization |
| 01/27/1999 | EP0893503A2 Regulator protein from Staphylococcus aureus |
| 01/27/1999 | EP0893499A2 Tetracycline resistance protein from Staphylococcus aureus |
| 01/27/1999 | EP0892807A1 Gene family associated with neurosensory defects |
| 01/27/1999 | EP0892791A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors |
| 01/27/1999 | CN1206348A Extracts of shark cartilage |
| 01/27/1999 | CN1206010A 5H-thiazole [3,2-a] pyrimidine derivatives |
| 01/27/1999 | CN1206005A Novel inhibitors of bone reabsorption and antagonists of vitronectin receptors |
| 01/27/1999 | CN1041830C Peptide compound |
| 01/27/1999 | CN1041795C Ophthalmological preparation |
| 01/26/1999 | US5864043 Cardiovascular disorders and angiotensin antagonist |
| 01/26/1999 | US5863927 Dextromethorphan and an oxidase inhibitor for treating intractable conditions |
| 01/26/1999 | US5863892 Use of platelet derived growth factor in ophthalmic wound healing |
| 01/26/1999 | US5863562 Methods and composition for preserving media in the tip of a solution dispenser |
| 01/25/1999 | CA2238664A1 Novel regulator |
| 01/23/1999 | CA2238674A1 Novel tetracycline resistance protein |
| 01/23/1999 | CA2238665A1 Novel reductase |
| 01/23/1999 | CA2238611A1 Novel lyss |
| 01/23/1999 | CA2238608A1 Novel cyss |
| 01/21/1999 | WO1999002504A1 6-azauracil derivatives as il-5 inhibitors |
| 01/21/1999 | WO1999002189A1 Pharmaceutical compositions comprising an aldose reductase inhibitor and an ace inhibitor |
| 01/21/1999 | WO1999002166A1 Use of colchinol derivatives as vascular damaging agents |
| 01/21/1999 | WO1999002165A1 Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma |
| 01/21/1999 | WO1999002130A2 Storage-stable ophthalmic compositions comprising diclofenac and ofloxacin |
| 01/21/1999 | CA2294779A1 Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma |